Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zaman

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
SLAS Discovery : Advancing Life Sciences R & D|May 19, 2020
High-Throughput Fluorescence-Based Activity Assay for Arginase-1Yvonne Grobben, Nicole Willemsen-Seegers, Joost C M Uitdehaag, et al.
Molecular Cancer Therapeutics|July 29, 2017
TTK Inhibitors as a Targeted Therapy for <i>CTNNB1</i> (<b>β</b>-catenin) Mutant CancersGuido J R Zaman, Jeroen A D M de Roos, Marion A A Libouban, et al.
Biopharmaceutics & Drug Disposition|January 1, 1990
Effect of dietary fat content on the bioavailability of a sustained release quinidine gluconate tabletM N Martinez, F R Pelsor, V P Shah, et al.
Cellular Signalling|November 20, 2012
β-Arrestin-biased signaling of PTH analogs of the type 1 parathyroid hormone receptorMiranda M C van der Lee, Folkert Verkaar, Jesse W Y Wat, et al.
Journal of Biomolecular Screening|June 13, 2009
Pharmacological characterization of receptor redistribution and beta-arrestin recruitment assays for the cannabinoid receptor 1Miranda M C van der Lee, Marion Blomenröhr, Antoon A van der Doelen, et al.
Journal of Molecular Biology|January 4, 2017
Compound Selectivity and Target Residence Time of Kinase Inhibitors Studied with Surface Plasmon ResonanceNicole Willemsen-Seegers, Joost C M Uitdehaag, Martine B W Prinsen, et al.
Angewandte Chemie (International Ed. in English)|April 12, 2017
Optimized Target Residence Time: Type I1/2 Inhibitors for p38α MAP Kinase with Improved Binding Kinetics through Direct Interaction with the R-SpineHeike K Wentsch, Niklas M Walter, Mike Bührmann, et al.
British Journal of Cancer|January 21, 2021
Comparative analysis of drug response and gene profiling of HER2-targeted tyrosine kinase inhibitorsNeil T Conlon, Jeffrey J Kooijman, Suzanne J C van Gerwen, et al.
Cell Cycle (Georgetown, Tex.)|July 8, 2015
Chromosomal instability, tolerance of mitotic errors and multidrug resistance are promoted by tetraploidization in human cellsAnastasia Y Kuznetsova, Katarzyna Seget, Giuliana K Moeller, et al.
Plos One|March 22, 2014
Comparison of the cancer gene targeting and biochemical selectivities of all targeted kinase inhibitors approved for clinical useJoost C M Uitdehaag, Jeroen A D M de Roos, Antoon M van Doornmalen, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
SLAS Discovery : Advancing Life Sciences R & D|May 19, 2020
High-Throughput Fluorescence-Based Activity Assay for Arginase-1Yvonne Grobben, Nicole Willemsen-Seegers, Joost C M Uitdehaag, et al.
Molecular Cancer Therapeutics|July 29, 2017
TTK Inhibitors as a Targeted Therapy for <i>CTNNB1</i> (<b>β</b>-catenin) Mutant CancersGuido J R Zaman, Jeroen A D M de Roos, Marion A A Libouban, et al.
Biopharmaceutics & Drug Disposition|January 1, 1990
Effect of dietary fat content on the bioavailability of a sustained release quinidine gluconate tabletM N Martinez, F R Pelsor, V P Shah, et al.
Cellular Signalling|November 20, 2012
β-Arrestin-biased signaling of PTH analogs of the type 1 parathyroid hormone receptorMiranda M C van der Lee, Folkert Verkaar, Jesse W Y Wat, et al.
Journal of Biomolecular Screening|June 13, 2009
Pharmacological characterization of receptor redistribution and beta-arrestin recruitment assays for the cannabinoid receptor 1Miranda M C van der Lee, Marion Blomenröhr, Antoon A van der Doelen, et al.
Journal of Molecular Biology|January 4, 2017
Compound Selectivity and Target Residence Time of Kinase Inhibitors Studied with Surface Plasmon ResonanceNicole Willemsen-Seegers, Joost C M Uitdehaag, Martine B W Prinsen, et al.
Angewandte Chemie (International Ed. in English)|April 12, 2017
Optimized Target Residence Time: Type I1/2 Inhibitors for p38α MAP Kinase with Improved Binding Kinetics through Direct Interaction with the R-SpineHeike K Wentsch, Niklas M Walter, Mike Bührmann, et al.
British Journal of Cancer|January 21, 2021
Comparative analysis of drug response and gene profiling of HER2-targeted tyrosine kinase inhibitorsNeil T Conlon, Jeffrey J Kooijman, Suzanne J C van Gerwen, et al.
Cell Cycle (Georgetown, Tex.)|July 8, 2015
Chromosomal instability, tolerance of mitotic errors and multidrug resistance are promoted by tetraploidization in human cellsAnastasia Y Kuznetsova, Katarzyna Seget, Giuliana K Moeller, et al.
Plos One|March 22, 2014
Comparison of the cancer gene targeting and biochemical selectivities of all targeted kinase inhibitors approved for clinical useJoost C M Uitdehaag, Jeroen A D M de Roos, Antoon M van Doornmalen, et al.
Pageof 12